Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.28) by 28.57 percent. This is a 38.46 percent decrease over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $2.62 million which missed the analyst consensus estimate of $3.50 million by 25.11 percent. This is a 37.23 percent increase over sales of $1.91 million the same period last year.